Guardant Health Joins Forces With Dak Prescott's Faith Fight Finish Foundation and Feist-Weiller Cancer Center's Partners in Wellness to Boost Colon Cancer Screening in Underserved Communities
Foundation's grant to mobile cancer screening program in Louisiana allows individuals to be screened with Guardant's Shield™ blood test in their own community
Mobile screening events to be held during Colorectal Cancer Awareness Month (March) throughout northern and central Louisiana
PALO ALTO, Calif., March 05, 2025--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a collaboration with Dak Prescott's Faith Fight Finish Foundation and the mobile cancer screening program, Partners in Wellness, an initiative of LSU Health Shreveport and Ochsner LSU Health—Feist-Weiller Cancer Center, to increase colorectal cancer screening rates in northern and central Louisiana.
Nationwide, colorectal cancer is the second leading cause of cancer-related death, even though it is highly treatable when detected in early stages. An estimated 53,000 people in the U.S. died from the disease in 2024. Northern Louisiana has a particularly high colorectal cancer incidence rate, being home to 7 of the 11 highest prevalence areas in the state. Colon cancer is also more prevalent in African American populations, which represent 59% of Partners in Wellness patients.
Based out of Shreveport, Louisiana, Partners in Wellness brings mobile screening vans to more than 30 communities in northern and central Louisiana and offers critical cancer screenings that are open to everyone—regardless of insurance status or ability to pay. As a result of a generous gift from Dak Prescott's Faith Fight Finish Foundation, the program's vans will now offer the Shield blood test so that individuals can be screened for colon and rectal cancer with a simple blood draw taken right on the mobile unit. Colon cancer is one of four pillars of the foundation, in tribute to Prescott's mother, Margaret "Peggy" Prescott, who passed away in 2013 at the age of 52 after a courageous battle with Stage 4 colon cancer.
"Detecting colon cancer early—when it's treatable—can make all the difference in the outcome," said Prescott. "And now screening can be as simple and convenient as having your blood drawn. I'm grateful to be able to join forces with Guardant Health and Partners in Wellness to give more people in my home state of Louisiana the chance to complete their screening with a simple blood test, so they can have more time down the road to spend with family and friends."
Since 1999, the Partners in Wellness mobile cancer screening program has served more than 20,000 patients and provided more than 50,000 screenings at no cost to patients.
"Screening for early detection of colorectal cancer is critical in Louisiana, especially northern Louisiana, because this region has significantly higher occurrence and mortality rates from the disease than other parts of the country," said Dr. Richard Mansour, Interim Director of Feist-Weiller Cancer Center. "We're grateful for the way Dak is making it possible for so many people in our underserved communities to be screened much earlier for colon cancer."
Screening events during Colorectal Cancer Awareness Month
Partners in Wellness will be holding multiple mobile screening events during the month of March (Colorectal Cancer Awareness Month). Community members eligible for colorectal cancer screening will be able to receive a Shield blood test at these events regardless of their insurance status or ability to pay. Results of the test are available in about two weeks. For more information about a screening event near you or to make an appointment, contact Partners in Wellness at 1-800-582-4523 or visit their website.
About Guardant Health
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.
About Ochsner LSU Health Shreveport—Feist-Weiller Cancer Center
Ochsner LSU Health Shreveport – Feist-Weiller Cancer Center brings together specialists from many fields to provide outstanding cancer care to the people of north Louisiana and the surrounding region. In addition to providing comprehensive, multidisciplinary cancer care, Feist-Weiller Cancer Center (FWCC) gives patients access to national cancer clinical trials. Collaboration between cancer researchers and treating physicians fosters a better understanding of cancer and leads to life-saving research breakthroughs. FWCC is also educating future leading oncologists through LSU Health Shreveport's Hematology/Oncology Fellowship Program. As a designated Center of Excellence in Cancer Research, Treatment, and Education, Feist-Weiller Cancer Center offers preeminent care and services to patients across the region.
Guardant Health Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health's liquid biopsy tests or assays, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health's financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operation" and elsewhere in its Annual Report on Form 10-K for the year ended December 31, 2023, and any current and periodic reports filed with or furnished to the Securities and Exchange Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Health's views as of any date subsequent to the date of this press release.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250305489187/en/
Contacts
Guardant Health Contacts
Investor Contact: Zarak Khurshidinvestors@guardanthealth.com
Media Contact: Michael Weistpress@guardanthealth.com +1 317-371-0035
Partners in Wellness Contacts Laurie Priftislpriftis@lsuhsfoundation.org 318-861-0855
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
5 minutes ago
- Business Wire
Caring Together: Carefull to Partner with the Alzheimer's Association to Protect Families
NEW YORK--(BUSINESS WIRE)-- Carefull, the first financial safety platform built specifically for older adults and their families, is proud to support the Alzheimer's Association in raising awareness of the financial warning signs of cognitive decline and equipping families with tools to take early, protective action to prevent fraud and mistakes. Carefull is proud to support the care, services and research initiatives of the Alzheimer's Association. The Alzheimer's Association will provide information and resources aimed at helping families affected by dementia navigate financial challenges on Carefull's website. "Alzheimer's disease comes with a daily financial reality for families, and we are beyond proud to be working with the Alzheimer's Association to ensure financial safety is part of the cognitive health conversation" Share Designed to detect early behavioral signals and safeguard day-to-day finances, Carefull offers both a window into the early stages of cognitive change and a system to help preserve the financial independence and wellbeing of those affected. Carefull partners with financial institutions nationwide to bring these protections directly to the families they serve. Each year, more than 900,000 Americans develop Alzheimer's disease, with 7.2 million people aged 65 and older currently living with the condition. Behind each diagnosis is a network of loved ones offering critical support— nearly 12 million unpaid caregivers in the U.S. provide more than 19 billion hours of care annually for individuals with Alzheimer's or other dementias. 'We're committed to working with organizations that share our mission to protect and support older adults and their families. This effort is about helping families see what's happening sooner and act with confidence,' said Todd Rovak, Co-Founder of Carefull. 'Alzheimer's disease comes with a daily financial reality for families, and we are beyond proud to be working with the Alzheimer's Association to ensure financial safety is part of the cognitive health conversation.' Growing evidence shows that financial missteps—like missed bill payments, rising credit card debt, or unusual generosity—can signal early cognitive decline, including Alzheimer's. Research from institutions such as Johns Hopkins, Georgetown, and the National Institute on Aging suggests these behaviors may surface up to six years before a clinical diagnosis. Identifying these financial warning signs offers a powerful opportunity for early intervention and support. Carefull turns this insight into action, offering families and caregivers proactive tools that can detect behavioral changes in financial activity. Through real-time alerts, Carefull ScamCheck, trusted contact infrastructure, and an expert and empathetic care team, Carefull provides early signals that allow families to act before small issues become life-altering crises, and deploy a system to safeguard someone who may become vulnerable to inbound financial scams. Long before a diagnosis, subtle financial changes like missed bills, unusual spending, or increased vulnerability to scams, can be among the first signs that something is wrong. Early detection of Alzheimer's can make a significant difference in how families respond, plan, and care for a loved one. About Carefull Carefull is the first financial safety platform designed to protect aging adults and their families, from elder fraud, scams, and money mistakes. Built to support the unique needs of older adults, Carefull's proprietary AI provides 24/7 account monitoring, a suite of identity and home protections, along with expert resources to help families, advisors, and financial institutions safeguard families' financial well-being. Banks, credit unions, and wealth advisors use Carefull to deepen relationships across generations, provide proactive protection, and enhance trust with clients navigating both aging and financial caregiving for older adults. Recognized for its innovation in financial safety, Carefull partners with leading institutions to put financial care into financial services. Learn more at About the Alzheimer's Association The Alzheimer's Association is a worldwide voluntary health organization dedicated to Alzheimer's care, support and research. Our mission is to lead the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. Visit or call 800.272.3900.
Yahoo
9 minutes ago
- Yahoo
Award-Winning Toy Creator and Family Physician Team Launch Playhouse MD™ to Reimagine Pediatric Healthcare
The female-founded brand is on a mission to revolutionize the pediatric healthcare space with Playful Pediatrics™ LOS ANGELES, June 11, 2025 /PRNewswire/ -- Sisters Sydney Wiseman, an award-winning toy creator, and Dr. Kaitlin Wiseman, a trusted family physician, are shaping the future of pediatric healthcare with the launch of Playhouse MD™, the first brand built entirely around reimagining children's healthcare through the transformative power of play. Sick days are never easy, for kids or their caregivers. From giving medicine to a squirming baby to battling midnight boogers, these small yet recurring tasks can feel huge and stressful. Playhouse MD™ was born from those very moments, designed to bring comfort, connection and just a little more ease to pediatric care. Playhouse MD™ seamlessly combines pediatric healthcare with the universal language of play through its doctor-designed medical devices with kid-friendly characters and playful prompts. "As a doctor and mom of two, I know firsthand how challenging pediatric care can be," says Dr. Kaitlin Wiseman, Co-Founder and Chief Medical Officer of Playhouse MD™. "At Playhouse MD, we're not reinventing the science behind medical devices — we're reimagining the care experience. By telling a story through friendly characters like narwhals, butterflies and elephants, we help turn tough healthcare moments into playful, cooperative ones. The result isn't just more smiles; it's a stronger connection between children and their parents and a more positive relationship with healthcare." Turning their vision of doctor-designed medical devices supplemented by playful storytelling into a reality took more than innovation — it required assembling a world-class team of healthcare experts alongside a network of leading business minds and renowned play specialists. Each Playhouse MD™ medical device features a kid-friendly character design and includes the brand's signature Playful Prompts Guide, which helps empower both kids and adults. "As a toymaker, I've always believed in the magic of a child's imagination — it's pure, powerful and endlessly creative," says Sydney Wiseman, Co-Founder and Chief Play Officer of Playhouse MD™. "We saw a unique opportunity to bring that same spark into healthcare by reimagining everyday challenges through the lens of play. With our playful prompts and characters, our goal is to turn tough moments into imaginative ones and help kids feel more at ease, and give parents a little more peace of mind." Playhouse MD™'s innovative approach to transforming pediatric healthcare through play has also garnered support from industry leaders in the play space. "My life's work has been rooted in the belief that play is more than entertainment - it's a vital part of how children grow, learn and understand the world around them," says Alan Hassenfeld, former Chairman and CEO of Hasbro, Inc and investor in Playhouse MD™. "That same philosophy lives in Playhouse MD with their innovative approach that brings clinical care into a child's world with empathy, creativity and joy. By integrating play into healthcare, they're not only easing fear; they're building trust, confidence and lasting emotional well-being and I'm honored to partner with a team that's so aligned with my own personal values." Available now at the brand's debut collection includes: Booger Buddy™ — A Nasal Aspirator and Nasal Bulb that allows for quick and gentle congestion relief, because when your baby can't breathe easily, no one can rest. The Booger Buddy™ collection helps turn stuffy noses into manageable moments with friendly characters featuring optional soft lighting for bedtime use; suitable for all ages 0M+ Elephant Light-Up Nasal Aspirator $19.99: adult-controlled suction nasal aspirator with a fun elephant character design for less stressful booger removal; includes 10 disposable filters Narwhal Light-Up Nasal Bulb $17.99: nasal bulb for adult-controlled suctioning with a playful narwhal character to relieve nasal congestion; the removable horn tip allows for easy, thorough cleaning for no hidden mold Medicine Buddy™ — Medicine Dispensers with removable pacifier attachment allows for precise and fuss-free medication delivery; suitable for all ages 0M+ Riley the Rocket or Bella the Butterfly $16.99: two-piece design with a pacifier attachment and curved medicine channel to bypass baby's taste buds and help reduce spit-ups; includes one 5 mL and one 10 mL syringe Playhouse MD™ will also be rolling out at major retailers including Amazon, Babylist and Target, making it easier than ever for families to bring home their imaginative, child-friendly care essentials. About Playhouse MD™At Playhouse MD™, we believe a dose of play goes a long way — especially on sick days. That's why we're reimagining pediatric care through play, transforming some of the toughest healthcare moments in early childhood into playful, story-led experiences for modern families. Co-founded by sisters Dr. Kaitlin Wiseman, a trusted family physician, and Sydney Wiseman, an award-winning toy creator, along with serial entrepreneur Michael Kamins, Playhouse MD™ combines pediatric healthcare with playful stories and kid-friendly designs to deliver medical devices that aren't just functional, but truly transformational. Our mission is simple: to make healthcare moments less intimidating and a whole lot more engaging, turning chaos into calm and stress into smiles. For more information, visit PLAYHOUSE™, PLAYHOUSE MD™ and all product names, designations and logos are trademarks of Playhouse MD Inc. or Playhouse Method Inc. © 2025 Playhouse MD Inc. All rights reserved. Pat. View original content to download multimedia: SOURCE Playhouse MD™ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
11 minutes ago
- Business Wire
Survey of America's Doctors Reveals Biggest Opportunities, Current Gaps for AI
BOSTON--(BUSINESS WIRE)-- Inlightened, a tech-enabled insights platform that connects innovative client companies to a network of vetted healthcare professionals (HCPs), today announced the findings of a survey of U.S. physicians regarding AI. The findings reveal current usage and benefits, in addition to unrealized opportunities for novel solutions. The findings More than half – 57% – are currently using AI tools at work, such as ambient listening/clinical documentation, billing, chatbots, and diagnostics 26% are using AI tools because they believe they provide a competitive advantage Less than 1 in 3 (28%) say they feel prepared when it comes to leveraging AI's benefits and protecting patients from its risks Nearly 4 out of 10 (38%) said their organization does not have guidelines for the use of AI Half (52%) believe AI will be an ally in their current role. Of those: 29% believe AI will enable them to capture more revenue 40% believe it will both enable more accurate billing and help them design treatment plans for patients 3 out of 10 believe AI will be both an ally and a threat. Of those: 76% said AI is a potential threat because they could be held accountable for AI errors if patient data is misrepresented 57% said AI is a potential ally because it will help improve patient diagnoses 23% said AI is a potential threat because it will erode trust with their patients For those who feel unprepared to leverage AI's benefits and protect patients from its risks to feel more prepared: 55% said case studies/examples from colleagues/others in similar roles 45% said outside training (i.e., AI/tech expert outside my organization) 'These findings reveal significant opportunity for AI to drive responsible disruption across healthcare,' said Shelli Pavone, co-founder and president, Inlightened. 'America's doctors are ready and willing to try AI for a number of use cases, but need the right solutions to demonstrate both the business and [delivery of] care case. The opportunities are vast for companies to close existing gaps – e.g., AI for revenue capture – while addressing clinicians' concerns, such as AI's potential to erode trust between a doctor and patient and the question of accountability. I believe the companies that position themselves – and their solutions – as physicians' advocates will stand out and impact the future of healthcare.' According to the findings, 3 out of 10 clinicians feel their organization is behind in regards to developing guidelines for the use of AI, highlighting an opportunity – and need – for leaders to ensure those within their organizations have clear guidance for the inevitable adoption of AI tools. When asked what impact they believe AI will have on healthcare in the U.S., the top answers were: 'I believe AI will improve patient outcomes' – 55% 'I believe AI will reduce clinical burnout' – 50% 'I believe AI will lower healthcare costs' – 47% 'I believe AI will lead to increased data and security breaches' – 42% 'These results mirror the conversations I'm having with colleagues about the promises and risks of AI,' said Dr. Oren Mechanic, MD, MPH, MBA, practicing physician, professor, and strategic advisor. 'The technology's promise for improving both the delivery of care and patient outcomes is exciting, and we are currently at an important crossroad that could determine the future of healthcare in the U.S. With the widespread adoption of tools, there are still some gaps to fill, such as the dissemination of compliance guidance. These survey findings highlight the need for the right leadership to ensure we are pursuing AI's promises and mitigating its risks, such as privacy. As with many healthcare innovations, we will soon better understand all the ways this technology can help us improve our patients' – and our own – experience with the healthcare system.' Survey Methodology Inlightened sent the online survey to a randomized sample of its clinician experts and received 72 responses between March 4 and March 19, 2025. Inlightened is the go-to SaaS platform for healthcare innovation. We connect client organizations to on-demand insights, via an unparalleled network of curated, vetted, and engaged experts. In addition to being recognized among Forbes' Inaugural Next 1000, Inlightened has been featured in Crunchbase, Forbes, and MedCity News. We were acquired by part of the Jackson Healthcare® family of companies, in August of 2023, and continue to operate as an independent entity.
